News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PharMerica Comments on Federal Trade Commission Decision to Block Omnicare, Inc. (OCR)’s Hostile Tender Offer


1/30/2012 6:34:05 AM

LOUISVILLE, Ky.--(BUSINESS WIRE)--PharMerica Corporation (NYSE:PMC), a national provider of institutional pharmacy and hospital pharmacy management services, today commented on the decision by the Federal Trade Commission (FTC) to sue to block Omnicare’s (NYSE: OCR) unsolicited offer to acquire PharMerica.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES